BMI View: The rising consumption of generic medicines will reshape Mexico’s pharmaceutical industry.
We expect the prevalence of generic drugs to increase rapidly over the forecast period – driven by
government regulations supporting the sector and rising public awareness of off-patented medicines.
Headline Expenditure Projections
? Pharmaceuticals: MXN172.74bn (USD13.53bn) in 2013 to MXN184.46bn (USD14.19bn) in 2014;
+6.8% in local currency terms and +4.9% in US dollar terms. Forecast decreased from Q314 due to
increasing generic competition.
? Healthcare: MXN1,033.98bn (USD81.00bn) in 2013 to MXN1,121.58bn (USD86.28bn) in 2014; +8.5%
in local currency terms and +6.5% in US dollar terms. Forecast decreased from Q314 due to revised
historical data.

Table of Contents

BMI Industry View 7
SWOT 9
Political 11
Economic 12
Industry Forecast 13
Pharmaceutical Market Forecast 13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2010-2018) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2010-2018) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2010-2018) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2010-2018) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2010-2018) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2010-2018) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2010-2018) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Mexico 2010-2018) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2012-2018) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Mexico 2012-2018) 30
Other Healthcare Data 31
Key Risks To BMI's Forecast Scenario 31
Macroeconomic Forecasts 32
Economic Analysis 32
Table: Economic Activity (Mexico 2009-2018) 37
Industry Risk Reward Ratings 38
Americas Risk/Reward Index 38
Mexico Risk/Reward Index 44
Rewards 44
Risks 44
Market Overview 46
Industry Trends And Developments 48
Epidemiology 48
Healthcare Sector 50
Health Insurance 51
Healthcare Sector Funding 55
Medical Tourism 55
Table: Selected Countries' Medical Tourism Prices In 2011 (USD) 56
Table: List Of Hospitals In Mexico With Joint Commission International (JCI) Accreditation 57
Research & Development 58
Clinical Trials 59
Table: Clinical Trial Regulation In Mexico 60
Regulatory Development 62
Regulatory Development 62
Biologics And Biosimilar Guidelines 66
Intellectual Property Issues 70
Intellectual Property Challenges 72
Table: Mexican Marketing Applications In Alleged Violation Of Patent Rights 74
Counterfeit Drugs 74
Pricing & Reimbursement 76
Pricing Issues 78
Pricing Developments 80
Reimbursement Issues 82
Other Regulatory Developments 83
Competitive Landscape 84
Pharmaceutical Sector 84
Table: TOP 10 PHARMACEUTICAL COMPANIES IN MEXICO BY SALES 84
Pharmaceutical Distribution 86
Pharmaceutical Retail Sector 87
Table: IMSS Financial Indicators, 2000-11 (MXNmn) 88
Company Profile 90
Genomma Labs 90
Pfizer 96
GlaxoSmithKline (GSK) 99
Sanofi 102
Eli Lilly 105
Bristol-Myers Squibb 108
Novartis 111
Bayer 114
Boehringer Ingelheim 116
Merck KGaA 119
Roche 122
Demographic Forecast 126
Demographic Outlook 126
Table: Population Headline Indicators (Mexico 1990-2025) 127
Table: Key Population Ratios (Mexico 1990-2025) 127
Table: Urban/Rural Population & Life Expectancy (Mexico 1990-2025) 128
Table: Population By Age Group (Mexico 1990-2025) 128
Table: Population By Age Group % (Mexico 1990-2025) 129
Glossary 131
Methodology 133
Pharmaceutical Expenditure Forecast Model 133
Healthcare Expenditure Forecast Model 133
Notes On Methodology 134
Risk/Reward Index Methodology 135
Index Overview 136
Table: Pharmaceutical Risk/Reward Index Indicators 136
Indicator Weightings 137

List of Tables

Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2010-2018)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2010-2018)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2010-2018)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2010-2018)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2010-2018)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2010-2018)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2010-2018)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Mexico 2010-2018)
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2012-2018)
Table: Pharmaceutical Trade Data And Forecasts local currency (Mexico 2012-2018)
Table: Economic Activity (Mexico 2009-2018)
Table: Selected Countries' Medical Tourism Prices In 2011 (USD)
Table: List Of Hospitals In Mexico With Joint Commission International (JCI) Accreditation
Table: Clinical Trial Regulation In Mexico
Table: Mexican Marketing Applications In Alleged Violation Of Patent Rights
Table: TOP 10 PHARMACEUTICAL COMPANIES IN MEXICO BY SALES
Table: IMSS Financial Indicators, 2000-11 (MXNmn)
Table: Population Headline Indicators (Mexico 1990-2025)
Table: Key Population Ratios (Mexico 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Mexico 1990-2025)
Table: Population By Age Group (Mexico 1990-2025)
Table: Population By Age Group % (Mexico 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators